Everolimus is an mTOR inhibitor and a synthetic derivative of sirolimus. It is indicated for the prevention and treatment of rejection in all solid organ transplant recipients.

AccuSift provides high-performance competitive antibody pairs for everolimus detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.

Sensitivity: ELISA LOD: 0.5 ng/mL